Outcomes for COPD pharmacological trials: from lung function to biomarkersMario Cazzola, Emiel F.�M. Wouters, Paul Jones et al.|European Respiratory Journal|2008Cited by 856
Exercise‐induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA<sup>2</sup>LENK.‐H. Carlsen, Paul Van Cauwenberge, Sandra D. Anderson et al.|Allergy|2008Cited by 315
Platelet Activation Is Associated With Myocardial Infarction in Patients With PneumoniaRoberto Cangemi, Ines Ullo, Marco Casciaro et al.|Journal of the American College of Cardiology|2014Cited by 159
Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular EventsRoberto Cangemi, Filippo Toriello, Camilla Calvieri et al.|The American Journal of Cardiology|2015Cited by 126
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia?Roberto Cangemi, Camilla Calvieri, Tommaso Bucci et al.|Antioxidants and Redox Signaling|2013Cited by 29